Omnipaque (Iohexol)

Iohexol, the active ingredient in Omnipaque, is a non‑ionic, low‑osmolality contrast media presented as a sterile injectable solution for intravascular use. It is employed to enhance radiographic visualization of vascular structures and organ systems during diagnostic imaging procedures. GNH USA supplies Omnipaque as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

GNH USA supplies Omnipaque as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Omnipaque is a low‑osmolality iodinated contrast agent used in imaging that highlights vascular and organ structures.

- Angiography: Improves visualization of blood vessels during cerebral, coronary and peripheral angiographic studies. - Computed Tomography (CT): Enhances contrast of abdominal, thoracic, and head CT scans for better lesion detection. - Myelography: Provides clear delineation of the spinal canal and nerve roots during myelographic examinations. - Urography: Improves opacification of the urinary tract in intravenous pyelograms. - Venography: Facilitates detailed imaging of veins for thrombosis assessment.

Adverse reactions to Omnipaque vary from mild to severe and are related to its iodine content and osmolar properties.

Common Side Effects: - Warm‑like tastes and feel of the body ... -  ​    ...  ....  ... ... .... .... ... ... ... .... ... ... ... ... ... ...  -  .... ...  ... ... ... ... ...... .... ... ... ... ... ... ...  - ...  .... ...  ... ... ...

...